Proof-of-concept to Evaluate the Efficacy and Safety of Prednisone in Idiosyncratic Hepatotoxicity
Condition(s):Hepatotoxicity; Idiosyncratic Drug Effect; PrednisoneLast Updated:February 20, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Hepatotoxicity; Idiosyncratic Drug Effect; PrednisoneLast Updated:February 20, 2024Not yet recruiting
Condition(s):PreDiabetes; Diabetes Mellitus, Type 2; Obesity; Oral Dysbiosis; Mouth DiseaseLast Updated:September 15, 2023Not yet recruiting
Condition(s):Neuroinflammatory Response; PsychosisLast Updated:April 18, 2023Recruiting
Condition(s):DementiaLast Updated:January 31, 2023Completed
Condition(s):Healthy SubjectsLast Updated:November 2, 2022Active, not recruiting
Condition(s):Colon CancerLast Updated:December 19, 2022Unknown status
Condition(s):Diabetes Type 2; MalnutritionLast Updated:October 7, 2022Recruiting
Condition(s):Type 2 Diabetes; MalnutritionLast Updated:June 21, 2022Completed
Condition(s):ObesityLast Updated:September 26, 2022Not yet recruiting
Condition(s):CMV InfectionLast Updated:April 7, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.